|Insiders say that the biotech firm got too big for its britches--while putting all of its eggs into one basket|
But the company didn't survive--despite its talented scientists, deep pockets, and the prospect of a blockbuster product. And the factors that led to the inglorious fading away of this once-promising northern California firm could serve as a warning to other entrepreneurial hopefuls.
While former Cetus scientists and administrators interviewed for this article willingly describe a series of chronic problems besetting the company, they tend to agree that the fundamental flaw was Cetus' inclination to behave like a fully mature drug company instead of the adolescent it really was.
Many former top managers at...